… – COVID-19, caused by SARS-CoV-2 infection, has … therapeutic agents against this novel
virus. Hence, the situation demands an immediate need to explore all the plausible therapeutic …

… We focus on currently recommended therapeutic agents, … COVID-19 that either show no or
only limited therapeutic activity… demonstrate no efficacy against SARS-CoV-2 infection. Lastly, …

… post-exposure hydroxychloroquine therapy did not prevent SARS-CoV-2 infection in
healthy … ritonavir and chloroquine to model potent anti-SARS-CoV-2 therapy [Citation42,Citation43]. …

… , and the current status of vaccine and novel therapeutic intervention development. Moreover,
we … to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment. …

… proteases, blocking Coronavirus receptors like an angiotensin-converting enzyme (ACE2), …
therapy, which can bring a revolutionary change to curb the SARS-CoV-2/COVID-19 in the …

… therapies for treating SARS-CoV-2 infection are in progress. In this review, we discuss the
effect of SARS-CoV-2 … therapeutic approaches and vaccines in development to curb the …

… to fight SARS-CoV-2. In this review, we present a detailed perspective of SARS-CoV-2, from
its … status of currently available pharmaceuticals for the treatment of COVID-19 and vaccines, …

… ACE2 receptor, can be considered as effective vaccines against SARS-CoV-2. Here, we
aimed to review frontier therapeutics and vaccination strategies for SARS-CoV-2 (COVID-19). …

… inhibitors that target the main protease of SARS-CoV-2. We highlight novel inhibitors that
were only discovered during the COVID-19 pandemic, discussing their unique binding modes …

… Nevertheless, antibody therapy for SARS-CoV-2 still faces potential … This review summarizes
representative SARS-CoV-2 neutralizing … of COVID-19 preventive or therapeutic antibodies. …